FDA-Drug2026-07-29Class IICHEMICAL

Major Pharmaceuticals levothyroxine sodium 150 mcg tablets recalled for subpotency

LABEL MIX UPNationwide distribution

Major Pharmaceuticals levothyroxine tablets recalled for subpotency

Major Pharmaceuticals is recalling specific lots of levothyroxine sodium 150 mcg tablets because they contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and subpotent tablets may not provide the intended therapeutic dose. The affected lots are lot #N02167A (bag) and lot #N02167 (blister), both expiring in July 2026.

  • Check your levothyroxine bottle for NDC 55154-3563-0 (bag) or 0904-6956-61 (blister), lot #N02167 or N02167A, expiring 07/2026.
  • Contact your pharmacist or doctor if you have this medication.
  • Do not stop taking levothyroxine without talking to your doctor — stopping abruptly can be harmful.
  • Your pharmacist can provide a replacement with the correct potency.
Hazard

Subpotent Drug

Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3563-0; NDC Blister: 0904-6956-61

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0711-2026

More Major Pharmaceuticals recalls

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief